Name: Lefei HAN, Assistant Professor

　　Email: lfhan@sjtu.edu.cn

　　Office Tel: +8621 63846590*776974

　　Research Interest: Infectious Disease Epidemiology; Environmental Health Epidemiology; Global Health; One Health

Dr Lefei Han has joined the School of Global Health (SGH) at SHUMU in 2021. She completed her Bachelor degree in Preventive Medicine at Sichuan University in 2015; Master of Public Health in Infectious Disease at the University of Hong Kong in 2016 and Ph.D in infectious disease epidemiology at the Hong Kong Polytechnic University in 2021. She was a visiting scholar at the Columbia University in 2019.

Dr Han’s research interests include infectious disease epidemiology, environmental health epidemiology, global health, and One Health. As a member of Core Facilities and Data Science Center for One Health at SGH, she works on integrating health information through global publicly available data to evaluate health status and its determinants around the world. The main focuses of her current research include 1) investigating the disease dynamics of COVID-19 and influenza under varying non-pharmaceutical interventions, environmental conditions, mutated virus strains, etc.; 2) investigating the direct and indirect impact of COVID-19 on other causes of death (i.e., cardiovascular diseases, diabetes, renal failure, mental health, etc.) and the disparities by varied demographics; and 3) developing a tool to evaluate the One Health performance and identifying the gaps of One Health capacity building around the world. Specifically, she mainly focuses on the field of food security, which is one of the sub-fields of One Health. She also responds to develop and optimize the statistical model of this assessment tool. Her previous research primarily focused on: 1) transmission, seasonality, epidemiology, and clinical outcomes of respiratory infectious diseases; 2) evaluating the impacts of ambient and household environmental exposure on communicable/non-communicable diseases; 3) using wearable devices (GPS) to measure daily activity patterns and evaluating the related health impacts; 4) estimating the disease burden, prevalence, and trend of non-communicable diseases.

Dr Han had 37 research publications as of May 2023 with H index 14, and total citations over 1000. She received Young Scientist Award from the European Scientific Working group on Influenza (ESWI) Seventh Conference in 2020, Yangfan Programme from Shanghai Science and Technology Development Fund in 2023. She is the course coordinator of Global Health and One Health for bachelor's students, Principle of One Health for master's students, and the course developer of Data Science and Application for master's students. In addition, Dr Han serves as an academic reviewer of scientific manuscripts for more than 10 journals, including BMC Infectious Disease; BMC Public Health; Diabetes, Obesity & Metabolism; Frontiers in Medicine; Frontiers in Public Health and Scientific Report, etc.

Publications

A) First or Corresponding authorship

1.　Han L#, Zhao S#, Li S#, Gu S, Deng X, Yang L, & Ran J. (2023). Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022. Nature Cardiovascular Research, 1-12. [IF: NA]

2.　Li S#, Han L#, Shi H, Chong MK, Zhao S, & Ran J. (2022). Excess deaths from Alzheimer’s disease and Parkinson’s disease during the COVID-19 pandemic in the USA. Age and Ageing, 51(12), afac277. [IF: 12.783]

3.　Han L#,Zhao S#, Cao W, Javanbakht M, Ran J, & Sun S. (2021). Changes in renal failure mortality during the COVID-19 pandemic in the United States. Journal of Nephrology, 34(6): 2167-2170. [IF: 4.393]

4.　Han L# (co-first author), Zhao S#, Cao P, … & Ran J. (2021). How transportation restriction shapes the relationship between ambient nitrogen dioxide and COVID-19 transmissibility: an exploratory analysis. Frontiers in Public Health. 9:697491. [IF: 6.461]

5.　Ran J#, Zhao S#, Han L#(co-first author), Ge Y, … & Sun S. (2021) Increase in diabetes mortality associated with COVID-19 pandemic in the U.S. Diabetes Care, 44:e1-e2. [IF: 17.152]

6.　Li N#, Han L# (co-first author), Peng M, ... & Yang L. (2020). Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clinical Infectious Diseases. 71(16):2035-2041, [IF: 20.999]

7.　Han L, Ran J, Chan KH, … & Yang L. (2020). Indoor environmental factors and acute respiratory illness in a prospective cohort of community-dwelling older adults. Journal of Infectious Diseases, 222(6):967-978. [IF: 7.759]

8.　Ran J #, Song Y#, Zhuang Z#,Han L#, Zhao S#, (co-first author) … & Yang L*. (2020). Blood Pressure Control and Adverse Outcomes of COVID-19 Infection in Patients with Coexisting Hypertension in Wuhan, China. Hypertension Research, 43(11): 1267-1276. [IF: 5.528]

9.　Han L, Ran J, Mak YW, … & Yang L. (2019). Smoking and influenza-associated morbidity and mortality: a systematic review and meta-analysis. Epidemiology, 30(3):405-417. [IF: 4.860]

10.　Yue L#,Han L#(co-first author), Li Q, Zhong M, Wang J, Wan Z, ... & Yang L*. (2020). Anesthesia and infection control in cesarean section of pregnant women with COVID-19 infection: A descriptive study. Journal of Clinical Anesthesia, 66, 109908. [IF: 9.375]

11.　Qiang N, Gu SY, Wang XY, Zhang XX, Xia S, Zheng JX, ... & Han LF. (2022). A One Health information database based on standard bibliometric analysis. Science in One Health, 1, 100012. [IF: NA]

12.　Weng L, Huang J, Lou Y, Shi H, Ma Y, Gu S, ... & Han L. (2022). Comparison of the prevalence in opioid use among US adults with cardiac conditions before and during the COVID-19 pandemic. Frontiers in Public Health, 11, 388. [IF: 6.461]

13.　Yang Y, Zhao S, Zhang M, Han L. & Ran J. Prevalence of neurodevelopmental disorders among US children and adolescents in 2019 and 2020. Frontiers in Psychology, 13:997648. [IF: 4.232]

14.　Zhao S, Wang K, Chong MK, Musa SS, He M, Han L, ... & Wang MH. (2022). The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: A conceptual model for COVID-19. Journal of theoretical biology, 542, 111105. [IF: 2.405]

15.　Zhao S, Musa, SS, … Han L, … & Daihai He. (2021). The co-circulating transmission dynamics of SARS-CoV-2 Alpha and Eta variants in Nigeria: a retrospective modeling study of COVID-19. Journal of Global Health. 11:05028. [IF: 7.664]

16.　Zhao S, Ran J, & Han L. (2021). Exploring the interaction between E484K and N501Y substitutions of SARS-CoV-2 in shaping the transmission advantage of COVID-19 in Brazil: a Modeling Study. American Journal of Tropical Medicine and Hygiene, 1, 105(5):1247-1254. [IF: 3.707]

B) Co-authorship

1.　Zhao HQ, Fei SW, Yin JX, Li Q, Jiang TG, ...Han LF, … & Kassegne, K. (2022). Assessment of performance for a key indicator of One Health: evidence based on One Health index for zoonoses in Sub-Saharan Africa. Infectious Diseases of Poverty, 11(05), 74-86. [IF: 10.489]

2.　Chen SC, Cheng HL,Han LF, Wu GT, Zhang RY, Suen LKP, ... & Yeung WF. (2022). Parent-administered pediatric tuina for the treatment of attention deficit hyperactivity disorder symptoms: Process evaluation of a pilot randomized controlled trial. Complementary Therapies in Medicine, 70, 102854. [IF: 3.335]

3.　Zhang XX, Liu JS,Han LF, Xia S, Li SZ, Li OY, ... & Zhou XN. (2022). Towards a global One Health index: a potential assessment tool for One Health performance. Infectious Diseases of Poverty, 11(1), 1-15. [IF: 10.489]

4.　Zhang XX, Liu JS,Han LF, Simm G, Guo XK, & Zhou XN. (2022). One Health: new evaluation framework launched. Nature, 604(7907), 625-625. [IF: 69.504]

5.　Chen SC, Cheng HL,Han LF, Wu GT, Zhang RY, Suen LKP, ... & Yeung WF. (2022). Parent-administered pediatric tuina for the treatment of attention deficit hyperactivity disorder symptoms: Process evaluation of a pilot randomized controlled trial. Complementary Therapies in Medicine, 70, 102854. [IF:3.335]

6.　Yang L, Chan K L, Yuen JW, Wong FK,Han L, Ho HC, ... & Wong MS. (2021). Effects of Urban Green Space on Cardiovascular and Respiratory Biomarkers in Chinese Adults: Panel Study Using Digital Tracking Devices. JMIR cardio, 5(2), e31316. [IF: NA]

7.　Ran J, Zhang Y,Han L, Sun S, Zhao S, Shen C, ... & Tian L. (2021). The joint association of physical activity and fine particulate matter exposure with incident dementia in elderly Hong Kong residents. Environment International, 156, 106645. [IF: 13.353]

8.　Cao P, Song Y, Zhuang Z, Ran J, Xu L, Geng Y, Han L, ... & Yang L. (2021). Obesity and COVID-19 in adult patients with diabetes. Diabetes, 70(5):1061-1069. [IF: 9.337]

9. Ran J, Zhao S,Han L, Liao G, Wang K, Wang MH, & He D. (2020). A Re-analysis in Exploring the Association between Temperature and COVID-19 Transmissibility: An Ecological Study with 154 Chinese Cities. European Respiratory Journal. 56(2):2001253. [IF: 33.795]

10.　Ran J, Schooling C.M,Han L, Sun S, Zhao S, … & Tian, L. (2020). Long-term exposure to fine particulate matter and dementia incidence: A cohort study in Hong Kong. Environmental Pollution, 271:116303. [IF: 9.988]

11.　Tan L, Ma B, Lai X,Han L, Cap P, … Yang L*, & Zhang X*. (2020). Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China. International Journal of Infectious Diseases. S1201-9712(20)30571-3. [IF: 12.074]

12.　Ran J, Sun S,Han L, Zhao S, ... & Tian L. (2020). Fine particulate matter and cause-specific mortality in the Hong Kong elder patients with chronic kidney disease. Chemosphere, 247(2020):125913. [IF: 8.943]

13.　Zhao S,Han L, He D, Qin J*. (2020) Public awareness, news promptness and the measles outbreak in Hong Kong from March to April, 2019. Infectious Diseases, 52(4):284-290. [IF: 5.838]

14.　Ran J, Yang A, Sun S,Han L, ... & Lee R. (2020). Long-Term Exposure to Ambient Fine Particulate Matter and Mortality from Renal Failure: A Retrospective Cohort Study in Hong Kong. American Journal of Epidemiology. 189(6):602-612. [IF: 5.363]

15.　Zhuang Z, Cao P, Zhao S,Han L, He D and Yang L. (2021). The shortage of hospital beds for COVID-19 and non-COVID-19 patients during the lockdown of Wuhan, China. Annals of Translational Medicine. 9(3):200. [IF: 3.616]

16.　Ran J, Kioumourtzoglou MA, Sun S,Han L, ... & Tian L. (2020). Source-Specific Volatile Organic Compounds and Emergency Hospital Admissions for Cardiorespiratory Diseases. International Journal of Environmental Research and Public Health, 17(17), 6210. [IF: 4.614]

17.　Ran J, Zhao S,Han L, … & He D. (2020). Initial COVID-19 Transmissibility and Three Gaseous Air Pollutants (NO2, SO2, and CO): A Nationwide Ecological Study in China. Frontiers in medicine, 7, 571. [IF: 5.058]

18.　Ran J, Sun S, Yang A, Yang L,Han L, ... & Tian L*. (2019). Effects of ambient benzene and toluene on emergency COPD hospitalizations: A time series study in Hong Kong. Science of The Total Environment, 657, 28-35. [IF: 10.753]

19.　Ran J, Zhao S,Han L, Qiu Y, Cao P, ... & He D. (2020). Effects of particulate matter exposure on the transmissibility and case fatality rate of COVID-19: A Nationwide Ecological Study in China. Journal of Travel Medicine, 27(6), taaa133. [IF: 39.194]

20.　Ran J, Zhao S,Han L, Chen D, Yang Z, Yang L, Wang M, He D. The ambient ozone and COVID-19 transmissibility in China: a data-driven ecological study of 154 cities. Journal of Infection. 81(3):e9-e11. [IF: 38.637].

21.　Ran J, Zhao S,Han L, Chong MK, Qiu Y, Yang Y, ... & He D. (2020). The changing patterns of COVID-19 transmissibility during the social unrest in the United States: A nationwide ecological study with a before-and-after comparison. One Health. 12:100201. [IF: 9.000]